Nanologica’s Nomination Committee Proposes Thomas Eldered as New Board Member of Nanologica AB
Thomas Eldered, who recently left his position as CEO of Recipharm and who is Nanologica’s largest shareholder, is proposed as new member of the Board of Directors to be elected at the Annual General Meeting on May 27.Thomas Eldered holds a M.Sc. in Industrial and Management Engineering from Linköping Institute of Technology and is the co-founder of Recipharm AB, where he was also the CEO from 2008–2021. Before that, Thomas was the Vice President of Recip AB 1995–2007. The Nomination Committee is in addition proposing re-election of Gisela Sitbon, Mattias Bengtsson, Eva Byröd, Tomas